2,931
Views
34
CrossRef citations to date
0
Altmetric
Review Articles

The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms)

, , &
Pages 641-675 | Received 24 Dec 2015, Accepted 01 Apr 2016, Published online: 09 Jun 2016

References

  • Abe K, Kato N, Miki K, Nimura S, Suzuki M, Kiyota H, Onodera S, Oishi Y. 2002. Malignant mesothelioma of testicular tunica vaginalis. Int J Urol. 9:602–603.
  • Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP. 2011. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 60:304–319.
  • Alekshun TJ, Tao J, Sokol L. 2007. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol. 82:481–485.
  • Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJ, Pass HI, Kari C, Rodeck U, Rauscher FJ, III, et al. 1995. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol. 146:344–356.
  • Attanoos RL, Gibbs AR. 1997. Pathology of malignant mesothelioma. Histopathology. 30:403–418.
  • Attanoos RL, Griffin A, Gibbs AR. 2003. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology. 43:231–238.
  • Bandyopadhyay A, Bhattacharya S, Konar K. 2015. Preoperative cytological diagnosis of malignant mesothelioma of tunica vaginalis. Diagn Cytopathol. 43:850–854.
  • Barbera V, Rubino M. 1957. Papillary mesothelioma of the tunica vaginalis. Cancer. 10:183–189.
  • Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. 1999. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 80:880–888.
  • Bisceglia M, Dor DB, Carosi I, Vairo M, Pasquinelli G. 2010. Paratesticular mesothelioma. Report of a case with comprehensive review of literature. Adv Anat Pathol. 17:53–70.
  • Boorman G, Chapin R, Mitsumori K. 1990. Testis and epididymis. In: Boorman G, Eustis S, Elwell M, Montgomery C, Jr, MacKenzie W, editors. Pathology of the Fischer rat. Reference and Atlas. New York: Academic Press. p. 405–418.
  • Boyum J, Wasserman NF. 2008. Malignant mesothelioma of the tunica vaginalis testis: a case illustrating Doppler color flow imaging and its potential for preoperative diagnosis. J Ultrasound Med. 27:1249–1255.
  • Caldwell DJ. 1999. Review of mononuclear cell leukemia in F-344 rat bioassays and its significance to human cancer risk: a case study using alkyl phthalates. Regul Toxicol Pharmacol. 30:45–53.
  • Cameron TP, Hickman RL, Kornreich MR, Tarone RE. 1985. History, survival, and growth patterns of B6C3F1 mice and F344 rats in the National Cancer Institute Carcinogenesis Testing Program. Fundam Appl Toxicol. 5:526–538.
  • Chan J, Jaffe E, Ralfkiaer E, Ko JH. 2008b. Aggressive NK-cell leukemia. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, editors. World Health Organization classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press. p. 276–277.
  • Chan W, Foucar K, Morice W, Catovsky D. 2008a. T-cell large granular lymphocytic leukemia. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, editors. World Health Organization classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press. p. 272–273.
  • Chekol SS, Sun CC. 2012. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 136:113–117.
  • Chen JL, Hsu YH. 2009. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Kaohsiung J Med Sci. 25:77–81.
  • Cheung MM, Chan JK, Wong KF. 2003. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol. 40:221–232.
  • Cheville JC. 1999. Classification and pathology of testicular germ cell and sex cord-stromal tumors. Urol Clin North Am. 26:595–609.
  • Churg A. 2003. Paratesticular mesothelial proliferations. Semin Diagn Pathol. 20:272–278.
  • Cohen SM, Klaunig J, Meek ME, Hill RN, et al. 2004. Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci. 78:181–186.
  • Coleman GL, Barthold W, Osbaldiston GW, Foster SJ, Jonas AM. 1977. Pathological changes during aging in barrier-reared Fischer 344 male rats. J Gerontol. 32:258–278.
  • Cook JC, Klinefelter GR, Hardisty JF, Sharpe RM, Foster PM. 1999. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol. 29:169–261.
  • Creasy D, Bube A, de Rijk E, Kandori H, Kuwahara M, Masson R, Nolte T, Reams R, Regan K, Rehm S, et al. 2012. Proliferative and nonproliferative lesions of the rat and mouse male reproductive system. Toxicol Pathol. 40:40S–121S.
  • Davey FR, Moloney WC. 1970. Postmortem observations on Fischer rats with leukemia and other disorders. Lab Invest. 23:327–334.
  • Dieter MP, Jameson CW, French JE, Gangjee S, Stefanski SA, Chhabra RS, Chan PC. 1989. Development and validation of a cellular transplant model for leukemia in Fischer rats: a short-term assay for potential anti-leukemic chemicals. Leuk Res. 13:841–849.
  • Dieter MP, Jameson CW, Maronpot RR, Langenbach R, Braun AG. 1990. The chemotherapeutic potential of glycol alkyl ethers: structure-activity studies of nine compounds in a Fischer-rat leukemia transplant model. Cancer Chemother Pharmacol. 26:173–180.
  • Dieter MP, Maronpot RR, French JE. 1985. Comparison of the morphology and enzyme activity of mononuclear cells from Fischer 344 rats with either spontaneous or transplanted leukemia. Cancer Res. 45:4301–4307.
  • Dunnick JK, Eustis SL, Huff JE, Haseman JK. 1989. Two-year toxicity and carcinogenicity studies of ampicillin trihydrate and penicillin VK in rodents. Fundam Appl Toxicol. 12:252–257.
  • Dunning WF, Curtis MR. 1946. The respective roles of longevity and genetic specificity in the occurrence of spontaneous tumors in the hybrids between two inbred lines of rats. Cancer Res. 6:61–81.
  • Dunning WF, Curtis MR. 1957. A transplantable acute leukemia in an inbred line of rats. J Natl Cancer Inst. 19:845–853.
  • Elwell MR, Dunnick JK, Hailey JR, Haseman JK. 1996. Chemicals associated with decreases in the incidence of mononuclear cell leukemia in the Fischer rat. Toxicol Pathol. 24:238–245.
  • EPA. 2005. Guidelines for carcinogen risk assessment. EPA/630/P=03/001F. Washington, DC: Environmental Protection Agency. p. 166.
  • Erdogan S, Acikalin A, Zeren H, Gonlusen G, Zorludemir S, Izol V. 2014. Well-differentiated papillary mesothelioma of the tunica vaginalis: a case study and review of the literature. Korean J Pathol. 48:225–228.
  • Farkas LM, Szekely JG, Pusztai C, Baki M. 2000. High frequency of metastatic Leydig cell testicular tumours. Oncology. 59:118–121.
  • Fernandez GC, Tardaguila F, Rivas C, Trinidad C, Pesqueira D, Zungri E, San Miguel P. 2004. Case report: MRI in the diagnosis of testicular Leydig cell tumour. Br J Radiol. 77:521–524.
  • Friedman MA, Dulak LH, Stedham MA. 1995. A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol. 27:95–105.
  • Frith CH. 1988. Morphologic classification and incidence of hematopoietic neoplasms in the Sprague-Dawley rat. Toxicol Pathol. 16:451–457.
  • Frith CH, Ward JM, Chandra M. 1993. The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol. 21:206–218.
  • Gana BM, Windsor PM, Lang S, Macintyre J, Baxby K. 1995. Leydig cell tumour. Br J Urol. 75:676–678.
  • Garriga V, Serrano A, Marin A, Medrano S, Roson N, Pruna X. 2009. US of the tunica vaginalis testis: anatomic relationships and pathologic conditions. Radiographics. 29:2017–2032.
  • Gentile TC, Uner AH, Hutchison RE, Wright J, Ben-Ezra J, Russell EC, Loughran TP, Jr. 1994. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood. 84:2315–2321.
  • Gerris J, Schoysman R. 1984. Tunica vaginalis fluid (TVF): hormonal composition. Assessment of testosterone, 5 alpha-dihydrotestosterone, delta 4-androstenedione, dehydroepiandrosteronesulphate, estradiol, LH, FSH and PRL. Acta Eur Fertil. 15:205–216.
  • Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC. 1987. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 47:6180–6184.
  • Giannarini G, Dieckmann KP, Albers P, Heidenreich A, Pizzocaro G. 2010. Organ-sparing surgery for adult testicular tumours: a systematic review of the literature. Eur Urol. 57:780–790.
  • Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE. 1987. Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol. 138:1214–1216.
  • Goel A, Agrawal A, Gupta R, Hari S, Dey AB. 2008. Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos. Cases J. 1:310.
  • Gonzalez M, Merlani P, Egger JF, Pugin F, Morel P. 2007. Hemorrhagic shock caused by rupture of an intra-abdominal leydig cell tumour: case report. Case Rep Gastroenterol. 1:53–58.
  • Goodman D, Boorman G, Strandberg J. 1985. Selection and use of the B6C3F1 mouse and F344 rat in long-term assays for carcinogenicity. In: Millman H, Weisburger E, editors. Handbook of carcinogen testing. New Jersey: Noyes Publications. p. 282–320.
  • Goodman DG, Ward JM, Squire RA, Chu KC, Linhart MS. 1979. Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol. 48:237–248.
  • Goodman G, Wilson R. 1991. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data. Environ Health Perspect. 94:195–218.
  • Guney N, Basaran M, Karayigit E, Muslumanoglu A, Guney S, Kilicaslan I, Gulbarut S. 2007. Malignant mesothelioma of the tunica vaginalis testis: a case report and review of the literature. Med Oncol. 24:449–452.
  • Hamm M, Rupp C, Rottger P, Rathert P. 1999. [Malignant mesothelioma of the tunica vaginalis testis]. Chirurg. 70:302–305.
  • Harada T, Maronpot RR, Morris RW, Boorman GA. 1990. Effects of mononuclear cell leukemia on altered hepatocellular foci in Fischer 344 rats. Vet Pathol. 27:110–116.
  • Hart DN, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, Rowe M, Beard ME. 1992. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood. 79:2116–2123.
  • Haseman JK. 1983. A reexamination of false-positive rates for carcinogenesis studies. Fundam Appl Toxicol. 3:334–339.
  • Haseman JK, Hailey JR, Morris RW. 1998. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol. 26:428–441.
  • Haseman JK, Huff JE, Rao GN, Arnold JE, Boorman GA, McConnell EE. 1985. Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst. 75:975–984.
  • Haseman JK, Ney E, Nyska A, Rao GN. 2003. Effect of diet and animal care/housing protocols on body weight, survival, tumor incidences, and nephropathy severity of F344 rats in chronic studies. Toxicol Pathol. 31:674–681.
  • Haseman JK, Rao GN. 1992. Effects of corn oil, time-related changes, and inter-laboratory variability on tumor occurrence in control Fischer 344 (F344/N) rats. Toxicol Pathol. 20:52–60.
  • Haseman JK, Young E, Eustis SL, Hailey JR. 1997. Body weight-tumor incidence correlations in long-term rodent carcinogenicity studies. Toxicol Pathol. 25:256–263.
  • Hassan R, Alexander R. 2005. Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am. 19:1067–1087, vi.
  • Hasserjian RP, Harris NL. 2007. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol. 127:860–868.
  • Hellman S, Moloney WC, Meissner WA. 1982. Paradoxical effect of radiation on tumor incidence in the rat: implications for radiation therapy. Cancer Res. 42:433–436.
  • Hendry J, Fraser S, White J, Rajan P, Hendry DS. 2015. Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience. Springerplus. 4:20.
  • Hiraga K, Fujii T. 1985. Carcinogenicity testing of acetaminophen in F344 rats. Jpn J Cancer Res. 76:79–85.
  • Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. 2003. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 200:370–374.
  • Huff JE. 1994. Chemicals causally associated with cancers in humans and laboratory animals. A perfect concordance. In: Waalkes MP, Ward JM, editors. Carcinogenesis. New York: Raven Press. p. 25–37.
  • Hursting SD, Switzer BR, French JE, Kari FW. 1993. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res. 53:2750–2757.
  • Hursting SD, Switzer BR, French JE, Kari FW. 1994. Inhibition of rat mononuclear cell leukemia by corn oil gavage: in vivo, in situ and immune competence studies. Carcinogenesis. 15:193–199.
  • Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, et al. 2013. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 137:647–667.
  • Ikegami Y, Kawai N, Tozawa K, Hayashi Y, Kohri K. 2008. Malignant mesothelioma of the tunica vaginalis testis related to recent asbestos. Int J Urol. 15:560–561.
  • Ilgren E. 1993. Mesotheliomas of animals: a comprehensive tabular compendium of the world's literature. Oxford: CRC Press.
  • Ilgren EB, Wagner JC. 1991. Background incidence of mesothelioma: animal and human evidence. Regul Toxicol Pharmacol. 13:133–149.
  • Imai K, Yoshimura K, Yamaguchi K, Matsui E, Isaka H, Hashimoto K, Boorman G. 1990. Effects of dietary restriction on age-associated pathologic changes in F-344 rats. J Toxicol Pathol. 3:209–221.
  • Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S. 2011. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One. 6:e19246.
  • Johansson P, Bergmann A, Rahmann S, Wohlers I, Scholtysik R, Przekopowitz M, Seifert M, Tschurtschenthaler G, Webersinke G, Jager U, et al. 2015. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia. Int J Cancer. 138:121–124.
  • Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol. 85:154–168.
  • Jones MA, Young RH, Scully RE. 1995. Malignant mesothelioma of the tunica vaginalis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol. 19:815–825.
  • Karpe B, Fredricsson B, Svensson J, Ritzen EM. 1982. Testosterone concentration within the tunica vaginalis of boys and adult men. Int J Androl. 5:549–556.
  • Kato R, Matsuda Y, Maehana T, Miyao N, Konishi Y, Kon S. 2012. Intrascrotal malignant mesothelioma diagnosed after surgery for hydrocele testis: a case report. Hinyokika Kiyo. 58:45–48.
  • Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, Asamura H, Tsuchiya R, Matsuno Y. 2007. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 20:215–220.
  • Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K. 1989. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 84:51–55.
  • Kim I, Young RH, Scully RE. 1985. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol. 9:177–192.
  • King-Herbert A, Thayer K. 2006. NTP workshop: animal models for the NTP rodent cancer bioassay: stocks and strains – should we switch? Toxicol Pathol. 34:802–805.
  • King-Herbert AP, Sills RC, Bucher JR. 2010. Commentary: update on animal models for NTP studies. Toxicol Pathol. 38:180–181.
  • Kivipensas P, Bjorkqvist AM, Karhu R, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Kallioniemi QP, Knuutila S. 1996. Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet. 89:7–13.
  • Kodell RL, Blackwell BN, Bucci TJ, Greenman DL. 1995. Cause-of-death assignment at the National Center for Toxicological Research. Toxicol Pathol. 23:241–247.
  • Kusewitt D, Hahn F, Pickerell J. 1982. Hematologic and serum chemical characteristics of mononuclear leukemia in Fischer 344 rats. Lab Anim Sci. 32:275–277.
  • Lafferty JS, Kamendulis LM, Kaster J, Jiang J, Klaunig JE. 2004. Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat. Toxicol Lett. 154:95–103.
  • Lagana SM, Taub RN, Borczuk AC. 2012. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions. Arch Pathol Lab Med. 136:804–809.
  • Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, Schüz J, Bray F. 2014. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer. 50:831–839.
  • Lee AF, Gown AM, Churg A. 2013. IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am J Surg Pathol. 37:421–426.
  • Lee S, Illei PB, Han JS, Epstein JI. 2014. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases. Am J Surg Pathol. 38:54–59.
  • Libé R, Fratticci A, Lahlou N, Jornayvaz FR, Tissier F, Louiset E, Guibourdenche J, Vieillefond A, Zerbib M, Bertherat J. 2012. A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutation. J Androl. 33:578–584.
  • Lindsey J. 1979. Historical foundations. In: Baker H, Lindsey J, Weisbroth S, editors. The laboratory rat. Vol. 1. Biology and diseases. New York: Academic Press. p. 2–33.
  • Lington AW, Bird MG, Plutnick RT, Stubblefield WA, Scala RA. 1997. Chronic toxicity and carcinogenic evaluation of diisononyl phthalate in rats. Fundam Appl Toxicol. 36:79–89.
  • Lipman RD, Dallal GE, Bronson RT. 1999. Effects of genotype and diet on age-related lesions in ad libitum fed and calorie-restricted F344, BN, and BNF3F1 rats. J Gerontol A Biol Sci Med Sci. 54:B478–B491.
  • Losco PE, Ward JM. 1984. The early stage of large granular lymphocyte leukemia in the F344 rat. Vet Pathol. 21:286–291.
  • Maizlin ZV, Belenky A, Kunichezky M, Sandbank J, Strauss S. 2004. Leydig cell tumors of the testis: gray scale and color Doppler sonographic appearance. J Ultrasound Med. 23:959–964.
  • Maqdasy S, Bogenmann L, Batisse-Lignier M, Roche B, Franck F, Desbiez F, Tauveron I. 2015. Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature. Reprod Biol Endocrinol. 13:72.
  • Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Merler E, De Zotti R, et al. 2010. Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register. Occup Environ Med. 67:760–765.
  • Maronpot RR, Flake G, Huff J. 2004. Relevance of animal carcinogenesis findings to human cancer predictions and prevention. Toxicol Pathol. 32:40–48.
  • Maronpot RR, Thoolen RJ, Hansen B. 2015. Two-year carcinogenicity study of acrylamide in Wistar Han rats with in utero exposure. Exp Toxicol Pathol. 67:189–195.
  • Maronpot RR, Zeiger E, McConnell EE, Kolenda-Roberts H, Wall H, Friedman MA. 2009. Induction of tunica vaginalis mesotheliomas in rats by xenobiotics. Crit Rev Toxicol. 39:512–537.
  • Masoudi JF, Van Arsdalen K, Rovner ES. 1999. Organ-sparing surgery for bilateral leydig cell tumor of the testis. Urology. 54:744.
  • Mensi C, Pellegatta M, Sieno C, Consonni D, Riboldi L, Bertazzi PA. 2012. Mesothelioma of tunica vaginalis testis and asbestos exposure. BJU Int. 110:533–537.
  • Moloney WC, Boschetti AE, King V. 1969. Observations on leukemia in Wistar Furth rats. Cancer Res. 29:938–946.
  • Moloney WC, Boschetti AE, King VP. 1970. Spontaneous leukemia in Fischer rats. Cancer Res. 30:41–43.
  • Moloney WC, King VP. 1973. Reduction of leukemia incidence following splenectomy in the rat. Cancer Res. 33:573–574.
  • Morris JE, Sasser LB, Miller DL, Dagle GE, Rafferty CN, Ebi KL, Anderson LE. 1999. Clinical progression of transplanted large granular lymphocytic leukemia in Fischer 344 rats exposed to 60 Hz magnetic fields. Bioelectromagnetics. 20:48–56.
  • Nolte T, Rittinghausen S, Kellner R, Karbe E, Kittel B, Rinke M, Deschl U. 2011. RITA-Registry of Industrial Toxicology Animal data: the application of historical control data for Leydig cell tumors in rats. Exp Toxicol Pathol. 63:645–656.
  • Nyska A, Hester SD, Cooper RL, Goldman JM, Stoker TE, House D, Wolf DC. 2002. Single or group housing altered hormonal physiology and affected pituitary and interstitial cell kinetics. J Toxicol Sci. 27:449–457.
  • Nyska A, Leininger JR, Maronpot RR, Haseman JK, Hailey JR. 1998. Effect of individual versus group caging on the incidence of pituitary and Leydig cell tumors in F344 rats: proposed mechanism. Med Hypotheses. 50:525–529.
  • Ohshima K, Suzumiya J, Kanda M, Kato A, Kikuchi M. 1998. Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett. 122:43–50.
  • Ozyavuz R, Ozen HA, Gedikoglu G, Ozgu IH, Sahin A, Tekgul S, Remzi D. 1993. Leydig cell tumour of the testis: presentation of two cases. Int Urol Nephrol. 25:385–388.
  • Pacheco AJ, Torres JL, de la Guardia FV, Arrabal Polo MA, Gomez AZ. 2009. Intraparenchymatous adenomatoid tumor dependent on the rete testis: a case report and review of literature. Indian J Urol. 25:126–128.
  • Peterson JT, Jr, Greenberg SD, Buffler PA. 1984. Non-asbestos-related malignant mesothelioma. A review. Cancer. 54:951–960.
  • Plas E, Riedl CR, Pfluger H. 1998. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Cancer. 83:2437–2446.
  • Poullot E, Zambello R, Leblanc F, Bareau B, De March E, Roussel M, Boulland ML, Houot R, Renault A, Fest T, et al. 2014. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol. 25:2030–2035.
  • Prentice DE, Siegel RA, Donatsch P, Qureshi S, Ettlin RA. 1992. Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat. Arch Toxicol Suppl. 15:197–204.
  • Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. 2005. International patterns and trends in testis cancer incidence. Int J Cancer. 115:822–827.
  • Rajan V, Nandhakumar R, Shanmugasundaram S, Ravi R, Natarajan S, Mohan G, Nanjundappan PM. 2013. Paratesticular malignant mesothelioma – a rare case presentation. Indian J Surg. 75:174–176.
  • Rall DP, Hogan MD, Huff JE, Schwetz BA, Tennant RW. 1987. Alternatives to using human experience in assessing health risks. Annu Rev Public Health. 8:355–385.
  • Rao G, Boorman G. 1990. History of the F344 rat. In: Boorman G, Eustis S, Elwell M, Montgomery C, Jr, MacKenzie W, editors. Pathology of the Fischer rat. Reference and Atlas. New York: Academic Press. p. 5–8.
  • Rao GN, Haseman JK. 1993. Influence of corn oil and diet on body weight, survival, and tumor incidences in F344/N rats. Nutr Cancer. 19:21–30.
  • Rao GN, Haseman JK, Grumbein S, Crawford DD, Eustis SL. 1990. Growth, body weight, survival, and tumor trends in F344/N rats during an eleven-year period. Toxicol Pathol. 18:61–70.
  • Reynolds CW. 1985. Large granular lymphocyte (LGL) lymphoproliferative diseases: naturally cytotoxic tumors in man and experimental animals. Crit Rev Oncol Hematol. 2:185–208.
  • Reynolds CW, Bere EW, Jr, Ward JM. 1984. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J Immunol. 132:534–540.
  • Reynolds CW, Bonyhadi M, Herberman RB, Young HA, Hedrick SM. 1985. Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines. J Exp Med. 161:1249–1254.
  • Ruskova A, Thula R, Chan G. 2004. Aggressive natural killer-cell leukemia: report of five cases and review of the literature. Leuk Lymphoma. 45:2427–2439.
  • Ryder J, Wang X, Bao L, Gross SA, Hua F, Irons RD. 2007. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol. 85:18–25.
  • Sacksteder MR. 1976. Occurrence of spontaneous tumors in the germfree F344 rat. J Natl Cancer Inst. 57:1371–1373.
  • Sass B, Rabstein LS, Madison R, Nims RM, Peters RL, Kelloff GJ. 1975. Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J Natl Cancer Inst. 54:1449–1456.
  • Sasser LB, Morris JE, Miller DL, Rafferty CN, Ebi KL, Anderson LE. 1996. Exposure to 60 Hz magnetic fields does not alter clinical progression of LGL leukemia in Fischer rats. Carcinogenesis. 17:2681–2687.
  • Schurkes C, Brock W, Abel J, Unfried K. 2004. Induction of 8-hydroxydeoxyguanosine by man-made vitreous fibres and crocidolite asbestos administered intraperitoneally in rats. Mutat Res. 553:59–65.
  • Segura-Gonzalez M, Urias-Rocha J, Castelan-Pedraza J. 2015. Malignant mesothelioma of the tunica vaginalis: a rare neoplasm-case report and literature review. Clin Genitourin Cancer. 13:e401–e405.
  • Semenzato G, Marino F, Zambello R. 2012. State of the art in natural killer cell malignancies. Int J Lab Hematol. 34:117–128.
  • Sharpe RM, McNeilly AS. 1979. The effect of induced hyperprolactinaemia on Leydig cell function and LH-induced loss of LH-receptors in the rat testis. Mol Cell Endocrinol. 16:19–27.
  • Shiga A, Narama I. 2015. Hepatic lesions caused by large granular lymphocyte leukemia in Fischer 344 rats: similar morphologic features and morphogenesis to those of nodular regenerative hyperplasia (NRH) in the human liver. Toxicol Pathol. 43:852–864.
  • Shimokawa I, Yu BP, Higami Y, Ikeda T, Masoro EJ. 1993. Dietary restriction retards onset but not progression of leukemia in male F344 rats. J Gerontol. 48:B68–B73.
  • Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, Macdonald N, Clewell H, Allen B, Van Landingham C. 2006. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol. 36:481–608.
  • Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N, Rajpert-De Meyts E. 2003. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS. 111:1–9. discussion 9–11.
  • Sokol L, Loughran TP, Jr. 2006. Large granular lymphocyte leukemia. Oncologist. 11:263–273.
  • Song SY, Kim WS, Ko YH, Kim K, Lee MH, Park K. 2002. Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica. 87:1343–1345.
  • Stefanski S, Elwell M, Stromberg P. 1990. Spleen, lymph nodes, and thymus. In: Boorman G, Eustis S, Elwell M, Montgomery C, Jr, MacKenzie W, editors. Pathology of the Fischer rat. Reference and Atlas.New York: Academic Press. p. 369–394.
  • Stefanski SA, Greenwell A, Merrick BA, Brown TT, Reynolds SH. 1995. Proliferating cell nuclear antigen staining of Fischer-344/N rat spleens affected by large granular lymphocyte leukemia. Toxicol Pathol. 23:1–6.
  • Steinbach T, Maronpot R, Hardisty J. 2015. Human relevance of rodent Leydig cell tumors. In: Harbison R, Bourgeois M, Johnson G, editors. Hamilton & Hardy's industrial toxicology. New York: John Wiley & Sons. p. 1189–1196.
  • Steinway SN, LeBlanc F, Loughran TP. 2014. The pathogenesis and treatment of large granular lymphocyte leukemia. Blood Rev. 28:87–94.
  • Stromberg PC, Grants IS, Kociba GJ, Krakowka GS, Mezza LE. 1990. Serial syngeneic transplantation of large granular lymphocyte leukemia in F344 rats. Vet Pathol. 27:404–410.
  • Stromberg PC, Rojko JL, Vogtsberger LM, Cheney C, Berman R. 1983d. Immunologic, biochemical, and ultrastructural characterization of the leukemia cell in F344 rats. J Natl Cancer Inst. 71:173–181.
  • Stromberg PC, Vogtsberger LM. 1983a. Pathology of the mononuclear cell leukemia of Fischer rats. I. Morphologic studies. Vet Pathol. 20:698–708.
  • Stromberg PC, Vogtsberger LM, Marsh LR. 1983c. Pathology of the mononuclear cell leukemia of Fischer rats. III. Clinical chemistry. Vet Pathol. 20:718–726.
  • Stromberg PC, Vogtsberger LM, Marsh LR, Wilson FD. 1983b. Pathology of the mononuclear cell leukemia of Fischer rats. II. Hematology. Vet Pathol. 20:709–717.
  • Stromberg PC, Vogtsberger LM, McMurray DN, Marsh LR, Kotur MS, Brown CA. 1985. Behavior of transplanted large granular lymphocyte leukemia in Fischer 344 rats. Lab Invest. 53:200–208.
  • Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, Gondo H, Hino N, Mori H, Sugimori H, et al. 2004. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 18:763–770.
  • Taheri ZM, Mehrafza M, Mohammadi F, Khoddami M, Bahadori M, Masjedi MR. 2008. The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations. Arch Pathol Lab Med. 132:694–697.
  • Takeda M, Kasai T, Enomoto Y, Takano M, Morita K, Kadota E, Iizuka N, Maruyama H, Nonomura A. 2012. Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues. J Clin Pathol. 65:77–82.
  • Tanigawa H, Onodera H, Maekawa A. 1987. Spontaneous mesotheliomas in Fischer rats – a histological and electron microscopic study. Toxicol Pathol. 15:157–163.
  • Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, et al. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 43:1022–1025.
  • Thomas J, Haseman JK, Goodman JI, Ward JM, Loughran TP, Jr, Spencer PJ. 2007. A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessment. Toxicol Sci. 99:3–19.
  • Thurman JD, Bucci TJ, Hart RW, Turturro A. 1994. Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats. Toxicol Pathol. 22:1–9.
  • Tomatis L, Aitio A, Wilbourn J, Shuker L. 1989. Human carcinogens so far identified. Jpn J Cancer Res. 80:795–807.
  • Trabert B, Zugna D, Richiardi L, McGlynn KA, Akre O. 2013. Congenital malformations and testicular germ cell tumors. Int J Cancer. 133:1900–1904.
  • Triola MF. 2010. Elementary statistics. 11th ed. Boston: Pearson Education.
  • Tsitouridis I, Maskalidis C, Panagiotidou D, Kariki EP. 2014. Eleven patients with testicular leydig cell tumors: clinical, imaging, and pathologic correlation. J Ultrasound Med. 33:1855–1864.
  • Turek FW, Desjardins C. 1979. Development of Leydig cell tumors and onset of changes in the reproductive and endocrine systems of aging F344 rats. J Natl Cancer Inst. 63:969–975.
  • Turturro A, Blank K, Murasko D, Hart R. 1994. Mechanisms of caloric restriction affecting aging and disease. Ann N Y Acad Sci. 719:159–170.
  • Ulbright TM, Srigley JR, Hatzianastassiou DK, Young RH. 2002. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells. Am J Surg Pathol. 26:1424–1433.
  • Unluer E, Ozcan D, Altin S. 1990. Malignant Leydig cell tumour of the testis: a case report and review of the literature. Int Urol Nephrol. 22:455–460.
  • Versnel MA, Hagemeijer A, Bouts MJ, van der Kwast TH, Hoogsteden HC. 1988. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene. 2:601–605.
  • Vukina J, Chism DD, Sharpless JL, Raynor MC, Milowsky MI, Funkhouser WK. 2015. Metachronous bilateral testicular Leydig-like tumors leading to the diagnosis of congenital adrenal hyperplasia (adrenogenital syndrome). Case Rep Pathol. 2015:459318.
  • Ward J, Rehm S, Reynolds C. 1990. Tumours of the hematopoietic system. In: Turusov V, Mohr U, editors. Pathology of tumours in laboratory animals. Vol. 1. Tumours of the rat. Lyon: International Agency for Research on Cancer. p. 625–657.
  • Ward JM, Reynolds CW. 1983. Large granular lymphocyte leukemia. A heterogeneous lymphocytic leukemia in F344 rats. Am J Pathol. 111:1–10.
  • Weisburger EK. 1983. History of the bioassay program of the National Cancer Institute. Prog Exp Tumor Res. 26:187–201.
  • Weisburger JH, Rivenson A, Reinhardt J, Braley J, Pittman B, Zang E. 2002. On the occurrence of Leydig cell tumors in the F344 rat. Cancer Lett. 182:213–216.
  • Winstanley AM, Landon G, Berney D, Minhas S, Fisher C, Parkinson MC. 2006. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases. Am J Surg Pathol. 30:1–6.
  • Woodward PJ, Schwab CM, Sesterhenn IA. 2003. From the archives of the AFIP: extratesticular scrotal masses: radiologic-pathologic correlation. Radiographics. 23:215–240.
  • Woodward PJ, Sohaey R, O'Donoghue MJ, Green DE. 2002. From the archives of the AFIP: tumors and tumorlike lesions of the testis: radiologic-pathologic correlation. Radiographics. 22:189–216.
  • Xiao SY, Rizzo P, Carbone M. 2000. Benign papillary mesothelioma of the tunica vaginalis testis. Arch Pathol Lab Med. 124:143–147.
  • Yen CH, Lee CT, Su CJ, Lo HC. 2012. Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epididymitis? World J Surg Oncol. 10:238.
  • Zhang Q, Jing W, Ouyang J, Zeng H, George SK, Liu Z. 2014. Six cases of aggressive natural killer-cell leukemia in a Chinese population. Int J Clin Exp Pathol. 7:3423–3431.